p38 and p42/44 MAPKs Differentially Regulate Progesterone Receptor A and B Isoform Stabilization. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Mol Endocrinol Année : 2011

p38 and p42/44 MAPKs Differentially Regulate Progesterone Receptor A and B Isoform Stabilization.

Résumé

Progesterone receptor (PR) isoforms (PRA and PRB) are implicated in the progression of breast cancers frequently associated with imbalanced PRA/PRB expression ratio. Antiprogestins represent potential antitumorigenic agents for such hormone-dependent cancers. To investigate the mechanism(s) controlling PR isoforms degradation/stability in the context of agonist and antagonist ligands, we used endometrial and mammary cancer cells stably expressing PRA and/or PRB. We found that the antiprogestin RU486 inhibited the agonist-induced turnover of PR isoforms through active mechanism(s) involving distinct MAPK-dependent phosphorylations. p42/44 MAPK activity inhibited proteasome-mediated degradation of RU486-bound PRB but not PRA in both cell lines. Ligand-induced PRB turnover required neosynthesis of a mandatory down-regulating partner whose interaction/function is negatively controlled by p42/44 MAPK. Such regulation strongly influenced expression of various endogenous PRB target genes in a selective manner, supporting functional relevance of the mechanism. Interestingly, in contrast to PRB, PRA stability was specifically increased by MAPK kinase kinase 1-induced p38 MAPK activation. Selective inhibition of p42/p44 or p38 activity resulted in opposite variations of the PRA/PRB expression ratio. Moreover, MAPK-dependent PR isoforms stability was independent of PR serine-294 phosphorylation previously proposed as a major sensor of PR down-regulation. In sum, we demonstrate that MAPK-mediated cell signaling differentially controls PRA/PRB expression ratio at posttranslational level through ligand-sensitive processes. Imbalance in PRA/PRB ratio frequently associated with carcinogenesis might be a direct consequence of disorders in MAPK signaling that might switch cellular responses to hormonal stimuli and contribute towards pathogenesis.
Fichier principal
Vignette du fichier
inserm-00611160_edited.pdf (846.12 Ko) Télécharger le fichier
Figures_Khan.pdf (4 Mo) Télécharger le fichier
Manuscript_ME-11-1042.pdf (256.13 Ko) Télécharger le fichier
Suppl_Figures_Khan.pdf (599.81 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Origine : Fichiers produits par l'(les) auteur(s)
Origine : Fichiers produits par l'(les) auteur(s)
Format : Autre

Dates et versions

inserm-00611160 , version 1 (04-08-2012)

Identifiants

Citer

Junaid Ali Khan, Larbi Amazit, Catherine Bellance, Anne Guiochon-Mantel, Marc Lombes, et al.. p38 and p42/44 MAPKs Differentially Regulate Progesterone Receptor A and B Isoform Stabilization.: Distinct MAPKs regulate PRA and PRB stability. Mol Endocrinol, 2011, 25 (10), pp.1710-24. ⟨10.1210/me.2011-1042⟩. ⟨inserm-00611160⟩
115 Consultations
537 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More